$PBH
Prestige Consumer Healthcare Inc.
XNYS•Health Care•Pharmaceutical Preparations
$49.77
▼-0.30%-$0.150
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonatePrestige Consumer Healthcare Inc.
XNYS•Health Care•Pharmaceutical Preparations
Why is PBH down today? It is at $49.77 (-0.30%), and our scanner flagged it 54 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment PBH spikes, and full due diligence on PBH — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $PBH 54 times in the last 30 days. Create a free account to track $PBH, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
PBH is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on PBH today, peaking at 17.8x its normal volume.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Byom John E Director | Acquired (grant/award) | +3K | added 5.8% | 55K | n/a | Aug 4, 26 |
Clark Celeste A. Director | Acquired (grant/award) | +3K | added 22% | 17K | n/a | Aug 4, 26 |
Darecca James Director | Acquired (grant/award) | +3K | added 45% | 10K | n/a | Aug 4, 26 |
Kelly John F. Director | Acquired (grant/award) | +3K | added 61% | 8K | n/a | Aug 4, 26 |
Zier Dawn M. Director | Acquired (grant/award) | +3K | added 18% | 20K | n/a | Aug 4, 26 |
Zerillo Jeffrey Officer | Sold (automatic/other) | -351 | sold 0.8% | 42K | $18K at $52.28 | May 11, 26 |
Mekhail Adel Officer | Sold (automatic/other) | -487 | sold 1.9% | 26K | $27K at $54.59 | May 7, 26 |
Lombardi Ronald M. Officer | Sold (automatic/other) | -3K | sold 0.7% | 373K | $139K at $54.59 | May 7, 26 |
Sacco Christine Officer | Sold (automatic/other) | -991 | sold 1.4% | 72K | $54K at $54.59 | May 7, 26 |
Zerillo Jeffrey Officer | Sold (automatic/other) | -351 | sold 0.8% | 42K | $19K at $54.59 | May 7, 26 |
Zerillo Jeffrey Officer | Sold (automatic/other) | -305 | sold 0.7% | 42K | $17K at $54.36 | May 7, 26 |
Zerillo Jeffrey Officer | Sold (automatic/other) | -346 | sold 0.8% | 44K | $19K at $55.32 | May 5, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
PBH is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 2 unusual-volume and momentum alerts on PBH today, peaking at 17.8x its normal volume.
PBH last traded at $49.77, down 0.30% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The PBH Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged PBH 54 times in the last 30 days.
PBH (Prestige Consumer Healthcare Inc.) trades on XNYS, with a market cap of about $2.36B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge PBH for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$PBH discussion
Sign in to ask a question or join the discussion.